Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Behçet Coşar |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? / Behçet Coşar en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)
[artículo]
Título : Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? : Case series of 18 patients Tipo de documento: texto impreso Autores: Behçet Coşar, Autor ; Mustafa Ender Taner, Autor ; Hale Yapc Eser, Autor Fecha de publicación: 2022 Artículo en la página: pp. 169-173 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Clozapina, Agranulocitosis, Prolongación, Esquizofrenia, Olanzapina, Qetiapina, Antipsicótico Resumen: Clozapine is a well-known drug that is used in treatment-resistant schizophrenia, but granulocytopenia, which may lead to a potentially fatal condition such as agranulocytosis, limit its use. The question about which antipsychotic should be used after a diagnosis of clozapine-associated granulocytopenia is difficult to answer, because antipsychotics other than clozapine may also have hematologic toxicity, or they may prolong clozapine-associated granulocytopenia. Link: ./index.php?lvl=notice_display&id=29385
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 169-173[artículo] Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? : Case series of 18 patients [texto impreso] / Behçet Coşar, Autor ; Mustafa Ender Taner, Autor ; Hale Yapc Eser, Autor . - 2022 . - pp. 169-173.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 169-173
Palabras clave: Clozapina, Agranulocitosis, Prolongación, Esquizofrenia, Olanzapina, Qetiapina, Antipsicótico Resumen: Clozapine is a well-known drug that is used in treatment-resistant schizophrenia, but granulocytopenia, which may lead to a potentially fatal condition such as agranulocytosis, limit its use. The question about which antipsychotic should be used after a diagnosis of clozapine-associated granulocytopenia is difficult to answer, because antipsychotics other than clozapine may also have hematologic toxicity, or they may prolong clozapine-associated granulocytopenia. Link: ./index.php?lvl=notice_display&id=29385